0.00Open1.90Pre Close0 Volume38 Open Interest22.50Strike Price0.00Turnover0.00%IV-0.25%PremiumDec 20, 2024Expiry Date1.96Intrinsic Value100Multiplier25DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma12.23Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Sitio Royalties Stock Discussion
• $APi Group (APG.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $23
• $Axos Financial (AX.US)$ : KBW Upgrades to Outperform from Marketperform - PT $56 (from $52)
• $Bank of America (BAC.US)$: Societe Generale Upgrades to Buy from Hold - PT $37.50 (from $40.50)
• $Element Solutions (ESI.US)$ : Barclays Upgrades to Overweight from Equalweight - PT $22 (from $24)
• $Fate Therapeutics (FATE.US)$ : BMO Capital Upgrades...
• $Vita Coco (COCO.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $12 (from $10)
• $Diebold Nixdorf (DBD.US)$ : Wedbush Upgrades to Outperform from Neutral - PT $5
• $Eversource Energy (ES.US)$ : Guggenheim Upgrades to Buy from Neutral - PT $97 (from $92)
• $Howmet Aerospace (HWM.US)$ : Benchmark Upgrades to Buy from Neutral - PT $40
• $The Interpublic Group of Companies (IPG.US)$ : Wells Fargo Upgrades to Overweight...
• $Coupang (CPNG.US)$ : Credit Suisse Upgrades to Outperform from Neutral - PT $19 (from $28)
• $First Republic Bank (FRC.US)$ : Atlantic Equities Upgrades to Overweight from Neutral - PT $188 (from $210)
• $Sitio Royalties (STR.US)$ : RBC Capital Upgrades to Outperform from Sector Perform - PT $43 (from $36)
Downgrades
• $Duck Creek Technologies (DCT.US)$ : JMP Securities Downgrades to Market Perform from Market Outperform
•...
• $Axsome Therapeutics (AXSM.US)$ +39.1% (received from FDA proposed labeling for the its AXS-05 product candidate with respect to its New Drug Application for AXS-05 for the treatment of major depressive disorder)
• $Capricor Therapeutics (CAPR.US)$ +4% (announces statistically significant clinical benefits in skeletal muscle function in non-ambulant duchenne muscular dystrophy patients treated with CAP-1002 in HOPE-2 Open L...
• $ACADIA Pharmaceuticals (ACAD.US)$ : Jefferies Upgrades to Buy from Hold - PT $25 (from $22)
• $Arthur J. Gallagher (AJG.US)$ : RBC Capital Upgrades to Outperform from Sector Perform - PT $185 (from $182)
• $Apple Hospitality REIT Inc (APLE.US)$ : B.Riley Upgrades to Buy from Neutral - PT $19
• $AutoZone (AZO.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $2,420 (from $2,125)
• $Boeing (BA.US)$ : Citigroup Upgr...
No comment yet